# End-eXpiratory Occlusion Test to Predict fluId REsponsiveness in the Operating Room (EXPIRE)

> **NCT04399278** · NA · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 40 (actual)

## Conditions studied

- Hemodynamic Instability
- General Anesthesia
- Surgery
- Protective Mechanical Ventilation

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic Test: end-expiratory occlusion (EEO) test

## Key facts

- **NCT ID:** NCT04399278
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-03
- **Primary completion:** 2021-03-24
- **Final completion:** 2021-03-24
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04399278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04399278, "End-eXpiratory Occlusion Test to Predict fluId REsponsiveness in the Operating Room (EXPIRE)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04399278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
